We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
DTE Energy
DTE
$29.9B
| $35.5M | 0.08% |
408,847
+12,295
| +3% | +$1.04M |
|
|
FITB
252
Fifth Third Bancorp
FITB
$51.3B
| $35.5M | 0.08% |
1,397,250
+30,319
| +2% | +$808K |
|
253
Gen Digital
GEN
$16.5B
| $35.1M | 0.08% |
1,142,625
+23,339
| +2% | +$662K |
|
254
T. Rowe Price
TROW
$25.5B
| $34.8M | 0.08% |
510,605
+4,801
| +0.9% | +$340K |
|
|
CERN
255
DELISTED
Cerner Corp
CERN
| $34.6M | 0.08% |
587,095
+21,842
| +4% | +$1.18M |
|
256
Tesla
TSLA
$1.18T
| $34.5M | 0.08% |
1,857,750
+63,630
| +4% | +$1.08M |
|
257
Dollar Tree
DLTR
$24.8B
| $34.3M | 0.08% |
436,653
+10,728
| +3% | +$825K |
|
258
Eversource Energy
ES
$28.1B
| $34.2M | 0.08% |
581,794
+25,391
| +5% | +$1.44M |
|
259
KeyCorp
KEY
$23.8B
| $34M | 0.08% |
1,911,942
+64,351
| +3% | +$1.18M |
|
260
Dollar General
DG
$28.4B
| $33.8M | 0.08% |
484,917
+16,419
| +4% | +$1.2M |
|
261
Hershey
HSY
$37.3B
| $33.7M | 0.08% |
308,866
+12,335
| +4% | +$1.32M |
|
262
Equifax
EFX
$22B
| $33.7M | 0.08% |
246,581
+6,474
| +3% | +$824K |
|
263
Autodesk
ADSK
$51.8B
| $33.5M | 0.08% |
386,914
+7,843
| +2% | +$656K |
|
264
Realty Income
O
$61.1B
| $33.4M | 0.08% |
579,572
+34,387
| +6% | +$1.99M |
|
265
Nucor
NUE
$58.3B
| $33.3M | 0.08% |
557,464
+23,559
| +4% | +$1.44M |
|
266
Skyworks Solutions
SWKS
$9.2B
| $33.2M | 0.08% |
339,037
+8,771
| +3% | +$801K |
|
267
VF Corp
VFC
$5.92B
| $33.2M | 0.08% |
641,216
+13,744
| +2% | +$678K |
|
268
Mettler-Toledo International
MTD
$28.1B
| $33.2M | 0.08% |
69,257
+2,365
| +4% | +$1.08M |
|
269
Vornado Realty Trust
VNO
$7.65B
| $33.1M | 0.08% |
408,153
+24,087
| +6% | +$2.06M |
|
270
Regions Financial
RF
$26.4B
| $32.9M | 0.08% |
2,262,479
+48,258
| +2% | +$712K |
|
271
Estee Lauder
EL
$30.4B
| $32.8M | 0.08% |
386,862
+38,275
| +11% | +$3.16M |
|
|
CXO
272
DELISTED
CONCHO RESOURCES INC.
CXO
| $32.8M | 0.08% |
255,366
+6,266
| +3% | +$843K |
|
273
APA Corp
APA
$13B
| $32.7M | 0.08% |
637,047
+9,344
| +1% | +$525K |
|
274
Fortive
FTV
$18.2B
| $32.6M | 0.08% |
859,372
+74,339
| +9% | +$2.67M |
|
275
Newmont
NEM
$96.2B
| $32.6M | 0.08% |
989,123
+11,050
| +1% | +$386K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.